• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童慢性免疫性血小板减少症的临床结局:泰国一家三级中心38年的经验

Clinical outcome of childhood chronic immune thrombocytopenia: A 38-year experience from a single tertiary center in Thailand.

作者信息

Chotsampancharoen Thirachit, Sripornsawan Pornpun, Duangchoo Sarapee, Wongchanchailert Malai, McNeil Edward

机构信息

Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand.

Epidemiology Unit, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand.

出版信息

Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26598. Epub 2017 Apr 28.

DOI:10.1002/pbc.26598
PMID:28453897
Abstract

BACKGROUND

There is limited information on long-term follow-up and prognostic factors for remission among children diagnosed with chronic immune thrombocytopenia (ITP). The aim of this study was to determine clinical outcomes and factors influencing remission in childhood chronic ITP.

STUDY DESIGN

The hospital records of children aged 0-15 years diagnosed with chronic ITP were retrospectively reviewed. Kaplan-Meier curves were fit to estimate the median time to complete remission with 95% confidence intervals (CIs). Multivariate Cox proportional hazards regression models were used to identify independent factors for remission.

RESULTS

A total of 113 patients were included in the analysis. The number of children achieving complete remission was 49 (46%) and the median time to remission was 7.1 years (95% CI: 4.8-11.0). The remission rates at 3, 5, 10, and 20 years were 25, 43, 60, and 75%, respectively. Factors influencing remission were platelets >60 × 10 /L at the onset of chronic ITP (hazard ratio [HR]: 7.24, 95% CI: 3.0-17.5) and treatment with intravenous immunoglobulin (HR: 0.37, 95% CI: 0.16-0.84). Age, gender, and clinical factors at the time of newly diagnosed ITP including bleeding manifestations, onset of symptoms, and history of preceding infection and vaccination were not predictive of remission.

CONCLUSION

The spontaneous complete remission rates of chronic ITP were 43 and 60% at 5 and 10 years, respectively, and reached 75% at 20 years. A higher platelet level at diagnosis of chronic ITP and form of treatment were statistically significant indicators for achieving complete remission.

摘要

背景

关于慢性免疫性血小板减少症(ITP)患儿的长期随访及缓解的预后因素的信息有限。本研究的目的是确定儿童慢性ITP的临床结局及影响缓解的因素。

研究设计

对0至15岁诊断为慢性ITP的儿童的医院记录进行回顾性分析。采用Kaplan-Meier曲线估计完全缓解的中位时间及95%置信区间(CI)。使用多变量Cox比例风险回归模型确定缓解的独立因素。

结果

共有113例患者纳入分析。实现完全缓解的儿童有49例(46%),缓解的中位时间为7.1年(95%CI:4.8 - 11.0)。3年、5年、10年和20年的缓解率分别为25%、43%、60%和75%。影响缓解的因素为慢性ITP发病时血小板>60×10⁹/L(风险比[HR]:7.24,95%CI:3.0 - 17.5)及静脉注射免疫球蛋白治疗(HR:0.37,95%CI:0.16 - 0.84)。新诊断ITP时的年龄、性别及临床因素,包括出血表现、症状发作、既往感染和疫苗接种史,均不能预测缓解情况。

结论

慢性ITP的自发完全缓解率在5年和10年时分别为43%和60%,20年时达到75%。慢性ITP诊断时较高的血小板水平及治疗方式是实现完全缓解的统计学显著指标。

相似文献

1
Clinical outcome of childhood chronic immune thrombocytopenia: A 38-year experience from a single tertiary center in Thailand.儿童慢性免疫性血小板减少症的临床结局:泰国一家三级中心38年的经验
Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26598. Epub 2017 Apr 28.
2
Prognostic variables in newly diagnosed childhood immune thrombocytopenia.新诊断儿童免疫性血小板减少症的预后变量
Am J Hematol. 2004 Dec;77(4):358-62. doi: 10.1002/ajh.20205.
3
Predictive factors for resolution of childhood immune thrombocytopenia: Experience from a single tertiary center in Thailand.儿童免疫性血小板减少症缓解的预测因素:来自泰国一家三级中心的经验。
Pediatr Blood Cancer. 2017 Jan;64(1):128-134. doi: 10.1002/pbc.26178. Epub 2016 Aug 30.
4
Predictors of remission in children with newly diagnosed immune thrombocytopenia: Data from the Intercontinental Cooperative ITP Study Group Registry II participants.新诊断免疫性血小板减少症患儿缓解的预测因素:来自洲际合作免疫性血小板减少症研究组登记处II参与者的数据。
Pediatr Blood Cancer. 2018 Jan;65(1). doi: 10.1002/pbc.26736. Epub 2017 Aug 9.
5
Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.利妥昔单抗治疗与脾切除术在儿童慢性难治性免疫性血小板减少性紫癜中的回顾性分析
Blood Coagul Fibrinolysis. 2016 Jun;27(4):431-5. doi: 10.1097/MBC.0000000000000488.
6
High Remission Rate of Chronic Immune Thrombocytopenia in Children: Result of 20-Year Follow-Up.儿童慢性免疫性血小板减少症的高缓解率:20年随访结果
Yonsei Med J. 2016 Jan;57(1):127-31. doi: 10.3349/ymj.2016.57.1.127.
7
Outcome of chronic idiopathic thrombocytopenic purpura in children.儿童慢性特发性血小板减少性紫癜的转归。
Pediatr Blood Cancer. 2010 Mar;54(3):403-7. doi: 10.1002/pbc.22346.
8
Predictive factors of response to IVIG in pediatric immune thrombocytopenic purpura.儿童免疫性血小板减少性紫癜中静脉注射免疫球蛋白治疗反应的预测因素
Pediatr Int. 2018 Apr;60(4):357-361. doi: 10.1111/ped.13505. Epub 2018 Mar 2.
9
Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.抗-D免疫球蛋白与低剂量静脉注射免疫球蛋白治疗儿童慢性特发性血小板减少性紫癜的随机试验
Acta Haematol. 2006;115(1-2):46-52. doi: 10.1159/000089465.
10
Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.特发性血小板减少性紫癜:阿拉巴马儿童医院的一项为期10年的自然史研究。
Clin Pediatr (Phila). 2004 Oct;43(8):691-702. doi: 10.1177/000992280404300802.

引用本文的文献

1
The Prognostic Value of Platelet Kinetics Assessment in Pediatric Chronic Idiopathic Thrombocytopenic Purpura.血小板动力学评估在儿童慢性特发性血小板减少性紫癜中的预后价值
Diagnostics (Basel). 2025 Jul 16;15(14):1790. doi: 10.3390/diagnostics15141790.
2
Clinical and Laboratory Characteristics of Children with Chronic Idiopathic Thrombocytopenic Purpura.慢性特发性血小板减少性紫癜患儿的临床及实验室特征
Diagnostics (Basel). 2025 May 12;15(10):1217. doi: 10.3390/diagnostics15101217.
3
Chronic immune thrombocytopenic purpura in children: Clinical presentations and management.
儿童慢性免疫性血小板减少性紫癜:临床表现与治疗。
Tunis Med. 2024 Nov 5;102(11):916-921. doi: 10.62438/tunismed.v102i11.5117.
4
Sustained remission at long term follow-up in adolescents and young adults with chronic primary immune thrombocytopenia.慢性原发性免疫性血小板减少症青少年及青年患者长期随访中的持续缓解情况
Blood Adv. 2024 Dec 24;8(24):6183-6194. doi: 10.1182/bloodadvances.2024014381.
5
Experience with Pediatric Chronic Immune Thrombocytopenia over 30 Years in the Era before Eltrombopag.在艾曲泊帕时代之前30多年来小儿慢性免疫性血小板减少症的经验
Children (Basel). 2024 Aug 28;11(9):1051. doi: 10.3390/children11091051.
6
Long-term treatment with romiplostim and treatment-free platelet responses in children with chronic immune thrombocytopenia.慢性免疫性血小板减少症儿童中罗米司亭的长期治疗和无治疗血小板反应。
Haematologica. 2019 Nov;104(11):2283-2291. doi: 10.3324/haematol.2018.202283. Epub 2019 Mar 7.